E-cigarettes not drug, traders can resume sale, says Bombay high court

The FDA had on July 6 issued a show cause notice to GPI asking them why legal action should not be initiated against them for selling e-cigarettes and violating provisions of the Drugs and Cosmetics Act and the Cigarettes and Other Tobacco Products Act.

In a reprieve for e-cigarette manufacturers and distributors, the Bombay high court (HC) on Friday allowed them to resume sale of the product as it is not a drug. Observing that the action taken against them by the Food and Drugs Administration (FDA) was not sustainable, the HC directed it to release the seized stock of e-cigarettes.

Read more about this article here: https://www.hindustantimes.com/cities/e-cigarettes-not-drug-traders-can-resume-sale-says-bombay-high-court/story-5u2yAukIKlzTofvoU10F2J.html

Go to FAQOther Frequently Asked Questions

Leave a Reply

Your email address will not be published. Required fields are marked *